Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

134 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
134 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

The Continuing Promise of Non-Embryonic Stem Cells

Eugene C. Tarne
December 8, 2014
ClosePlease login
featured-image
Fetal Tissue, Stem Cells & Bioethics

Scientific Advances in Stem Cell Research Continue to Make Use of Embryos Outdated and Unnecessary

Diabetes has long been one of the main diseases for which human embryonic stem cell (embryo-destroying) research, or hESCR, was claimed to hold the greatest promise of curing. But for well over a decade now, ethically contentious human embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within “five to 10 years” remaining unfulfilled.

featured-image
Fetal Tissue, Stem Cells & Bioethics

The United Kingdom’s Rubicon on Three-Parent Embryos

Later this month, leading scientists from around the world are set to caution a UK parliamentary inquiry against the creation of babies using the genetic material of three parents.  On October 22, this group will warn the inquiry against such genetic engineering and the possible scientific and ethical problems it could bring.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Ethical Stem Cells Provide Model for Progress in Down Syndrome Research

Researchers using ethically uncontroversial induced pluripotent stem cells (iPSCs) have achieved what appears to be a major breakthrough in understanding the origin and development of Down syndrome, according to a new study recently published in Nature Communications.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Thailand Moves to Reform Law following Surrogacy Cases Gone Awry

Last week, Thailand officials announced a reform of its surrogacy legislation by way of a newly drafted bill that would ban commercial surrogacy.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Center for Bioethics and Culture Founder Releases Documentary on Harmful Effects of Surrogacy

Jennifer Lahl, founder of the Center for Bioethics and Culture and an award-winning film director, recently released her latest documentary entitled Breeders: A Subclass of Women? The new film examines the harmful consequences of surrogacy.  Breeders concludes her three-part film series on sexual reproductive technologies.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Cloning is Cloning is Cloning

This primer on cloning examines the nature and purpose of human cloning in light of recent developments in stem cell technology. The paper points out that all cloning is reproductive and reflects on the immediate outcome of human cloning - a human embryo - while examining the terminology used by cloning advocates to obscure the facts.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Ethical Stem Cells: Back to Basics

The California Institute for Regenerative Medicine’s (CIRM) initial round of grants for 2014 provides an interesting perspective on a pattern of research funding that has emerged at CIRM in recent years.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image